Ocuphire Pharma, Inc. insider trading activity

Understanding Insider Activity at Ocuphire Pharma, Inc.

Welcome to our dedicated page for Ocuphire Pharma, Inc. (: IRD) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Ocuphire Pharma, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Ocuphire Pharma, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for IRD
TickerTime & DateFilingLink
IRD9:08:37 PM, 11/19/2024
Magrath George(Chief Executive Officer) purchased 100000 shares of Opus Genetics, Inc. (IRD) for ~$101096
Filing